The U.S. Food and Drug Administration (FDA) has granted approval for an Abbreviated New Drug Application (ANDA) identified as 088750. The approved product is an oral tablet containing 2.5 mg of methyclothiazide and is marketed under the brand name Methyclothiazide (product number 001). The FDA’s records list the marketing status of this tablet as discontinued.
The approval timeline includes two submissions. The original submission (ORIG) numbered 1 received approval on September 6, 1984. A supplemental submission (SUPPL) numbered 3, classified under Manufacturing (CMC), was approved on December 23, 1985.
The sponsor responsible for the application is Watson Labs.
Cập nhật pháp chế16 thg 9, 2026•3 phút đọc
FDA Approves Methyclothiazide Tablet (ANDA 088750)
The FDA has approved ANDA 088750 for a 2.5 mg oral tablet of methyclothiazide submitted by Watson Labs; the product is listed as discontinued.
Tổng hợp bởi đội ngũ Pharmacountry · Nguồn: FDA.gov
Chủ đề:
Đánh giá
(0)
(0)
(0)
(0)
(0)
Để lại đánh giá